PrimeRFP SCOUT · Federal Contract Recompete Brief

N6264521F0055APTIMA sars-cov-2 ASSAY — Gen-Probe Inc

Gen-Probe Inc holds $112.5M across 5,120 federal awards. This PIID sits alongside 3 related awards under parent N6264520D5007. PoP ended Jan 21, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Naval Medical Logistics Command

Awarding office

Gen-Probe Inc

Recipient

Jan 21, 2021

PoP end

$0

Obligated

$319K

Potential

325413

NAICS

6515

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Gen-Probe Inc — $90

Contract facts

Federal

Contract numberN6264521F0055

Also listed asN62645-21-F-0055

Also listed asN6264520D5007-N6264521F0055

AgencyNaval Medical Logistics Command

Awarding officeNaval Medical Logistics Command

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentGen-Probe Inc

CAGE0BDV3

UEIQNXWLAJDL4J3

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDVN6264520D5007

Place of performanceMARLBOROUGH MA

Pricing typeFirm Fixed Price

Extent competedNot Competed

Related solicitationN6264520Q0017

PoP startJan 14, 2021

PoP end (current)Jan 21, 2021

Obligated$0

Current value$319K

Potential value$319K

APTIMA SARS-COV-2 ASSAY is a federal award for Naval Medical Logistics Command held by Gen-Probe Inc. Estimated value $319K ($0 obligated). Current period of performance ends Jan 21, 2021. Place of performance: MARLBOROUGH MA. Related solicitation N6264520Q0017.

Recompete timing

Public

● Past PoP end (2038 days ago)

Current PoP ended Jan 21, 2021 (2038 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Gen-Probe Inc — $112.5M obligated across 5,120 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$719K · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

W81K0222P0032

NUCLEIC ACID ACTIVE REAGENTS AND ASSAY KITS FOR PANTHER AND FUSION INSTRUMENTS FOR TAMC 03…

$2.0M

Sep 30, 2026

N3239822P0303

EXERCISE OPTION YEAR 4 SERVICE AGREEMENT N3239822P0303 FOR: PANTHER FUSION (SN: 2090003912…

$122K

May 19, 2027

W81K0022P0111

KIT, APTIMA COMBO 2 CT/GC 250 TEST

$2.2M

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract N6264521F0055?

N6264521F0055 (APTIMA sars-cov-2 ASSAY) is a Naval Medical Logistics Command award with a potential value of $319K, currently held by Gen-Probe Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is N62645-21-F-0055?

N62645-21-F-0055 is the dashed form of PIID N6264521F0055 (APTIMA sars-cov-2 ASSAY), held by Gen-Probe Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded N6264521F0055?

Naval Medical Logistics Command awarded N6264521F0055 to Gen-Probe Inc (potential $319K).

Who is the incumbent on N6264521F0055?

Gen-Probe Inc is the incumbent with $112.5M across 5120 related awards in SCOUT’s public footprint. The current period of performance ends Jan 21, 2021.

When does Gen-Probe Inc’s N6264521F0055 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 21, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Nov 5, 2021